BioCentury
ARTICLE | Company News

CHF deal for Scios, Medtronic

May 9, 2001 7:00 AM UTC

SCIO and MDT will use MDT's Chronicle Implantable Hemodynamic Monitor (IHM) and implantable infusion systems to study the hemodynamic effects of SCIO's Natrecor recombinant B-type natriuretic peptide....